Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW032 and Xgeva® in Healthy Adults
Condition(s):Bone TumorLast Updated:March 15, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Bone TumorLast Updated:March 15, 2021Completed
Condition(s):Anorexia NervosaLast Updated:January 7, 2019Terminated
Condition(s):Infertility, MaleLast Updated:February 29, 2024Recruiting
Condition(s):OsteoporosisLast Updated:March 12, 2015Completed
Condition(s):Denosumab AllergyLast Updated:March 14, 2023Withdrawn
Condition(s):Post Menopausal OsteoporosisLast Updated:March 10, 2020Completed
Condition(s):Charcot Joint of FootLast Updated:October 23, 2019Completed
Condition(s):Rheumatoid ArthritisLast Updated:October 25, 2021Completed
Condition(s):Metastatic Osteosarcoma; Recurrent Osteosarcoma; Refractory Osteosarcoma; Stage IV Osteosarcoma AJCC v7; Stage IVA Osteosarcoma AJCC v7; Stage IVB Osteosarcoma AJCC v7Last Updated:January 22, 2024Completed
Condition(s):Testis; Infertility; SpermLast Updated:March 27, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.